All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 27, 2021
Home » Blogs » BioWorld MedTech Perspectives » The real poop on IBD

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

The real poop on IBD

April 12, 2013
By Amanda Pedersen
No Comments

The card, available through MyIBD.org, reads: The holder of this card has Crohn's disease or ulcerative colitis. Colitis is painful and requires immediate access to a toilet facility. This patient cannot physically "hold it". Please make your restroom available.
MyIBD.org, reads: The holder of this card has Crohn's disease or ulcerative colitis. Colitis is painful and requires immediate access to a toilet facility. This patient cannot physically "hold it". Please make your restroom available.

Back in January a columnist for The Virginian-Pilot wrote an incredibly insensitive, misinformed, and elitist piece that had my friends with inflammatory bowel disease (IBD) losing their poop. Pun intended.

The column was written in reaction to a defeated bill that would have required businesses in Virginia to allow patients with Crohn’s disease or ulcerative colitis (collectively known as IBD), access to their restrooms. It would have served the columnist well to do a little research on IBD before equating the sufferers of this debilitating disease to a bunch of sticky-fingered thieves.

As I have mentioned in several previous blog posts, I suffered from ulcerative colitis all through college before eventually undergoing major surgery to remove my entire colon during my senior year. I would not wish Crohn’s or colitis on my worst enemy. Heck, I wouldn’t even wish it on that columnist from Virginia.

The issue of being denied restroom access has come up a number of times on a social forum provided on a mobile app called GI Monitor, designed specifically for people who suffer from IBD and related bowel ailments.

Once, about four months ago, one of my GI Monitor friends was shopping at a popular greeting card store when she was hit by the sudden urge that IBD sufferers are all too familiar with. And for the record, people with IBD cannot physically “hold it”.

My friend approached the counter, explained her condition and even showed her medical alert restroom card, a card designed to encourage shopkeepers to make their restroom available to people with IBD. Still, she was denied.

My friend did everything she could to convince them, but because they showed no compassion to her, she lost control of her bowels and had an accident in the middle of the busy store. It was a humiliating experience for her to say the least, but there was some justice in the end—the same employee who had denied her access to the restroom was forced to clean the mess on the carpet.

One of the store’s employees actually said to her, “you don’t look like a baby so there’s no excuse for what you did.” My friend appropriately replied, “Try living with a disease where you have no control of your bowels” and took her business elsewhere. No pun intended that time.

My point is that this condition, which the Virginian columnist inaccurately called a “rare disease”, is actually something that 1.4 million Americans have to live with. And while the columnist suggested that Crohn’s patients should launch a public relations campaign to raise awareness, I would point out to her that they already have. In fact, The Crohn’s and Colitis Foundation of America just won a national award for their “Escape the Stall” campaign. I highly encourage you to click here and watch the clip if you haven’t already seen it on TV.

IBD is so prevalent that I would be very surprised if the same store employee who snubbed my friend does not unknowingly have a close friend or family member affected by the disease. But because it is so painfully embarrassing, too many patients are afraid to come out of the, um, stall.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 26.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing